| Nombre del producto |
Levetiracetam |
| Sinónimos |
(s)-2-(2-oxopyrrolidin-1-yl)butanamide; (S)-1-pyrrolidineacetamid; (+-)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; 1-Pyrrolidineacetamide; alpha-ethyl-2-oxo-; alpha-Ethyl-2-oxo-1-pyrrolidineacetamide; Etiracetamum [INN-Latin]; Keppra; Levetiracetam [INN]; Levetiracetamum [INN-Latin]; LEVITIRACETAM; UCB 6474; UCB-6474; UCB-L 059; Name:(S)-2-(2-Oxopyrrolidin-1-yl)butanamide (Levetiracetam); (2R)-2-(2-oxopyrrolidin-1-yl)butanamide; (2S)-2-(2-oxopyrrolidin-1-yl)butanamide; Levetiracetame |
| Fórmula molecular |
C8H14N2O2 |
| Peso Molecular |
170.209 |
| InChI |
InChI=1/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1 |
| Número de registro CAS |
102767-28-2;51052-62-1 |
| Estructura Molecular |
|
| Densidad |
1.168g/cm3 |
| Punto de fusión |
118-119℃ |
| Punto de ebullición |
395.9°C at 760 mmHg |
| Índice de refracción |
1.518 |
| Punto de inflamación |
193.2°C |
|
